RSV Ag Rapid Test Device

Respiratory Syncytial Virus, commonly known as RSV, is a contagious respiratory virus that affects the lungs and breathing passages. RSV commonly causes mild cold-like symptoms but may become severe in infants, young children, older adults, and individuals with weakened immunity.

• The RSV Ag Rapid Test Device helps support fast screening of suspected RSV infection.
• RSV infections may cause cough, fever, wheezing, runny nose, sore throat, and breathing difficulty.
• Rapid testing is useful in pediatric clinics, hospitals, respiratory infection programs, and seasonal outbreak management.
• Fast RSV screening may help support patient management, infection-control measures, and respiratory illness monitoring.

The RSV Ag Rapid Test Device by LARKSOIS Pharma may be used in professional respiratory infection screening environments.

Applications

• Hospitals and clinics
• Pediatric care centers
• Emergency departments
• Diagnostic laboratories
• Respiratory infection screening programs
• Seasonal respiratory outbreak support
• Public health respiratory surveillance
• Professional point-of-care testing
• International diagnostic distribution

• The RSV Ag Rapid Test Device works on lateral flow immunochromatographic assay technology.
• After specimen collection, the nasal or nasopharyngeal swab is mixed with extraction buffer.
• The processed sample is then added to the test cassette.
• If RSV antigen is present, it reacts with specific antibodies on the membrane and forms a visible test line.
• The control line confirms correct sample migration and valid test performance.

The RSV Ag Rapid Test Device uses rapid lateral flow immunochromatographic technology for qualitative detection of Respiratory Syncytial Virus antigen in nasal or nasopharyngeal swab specimens.

Benefits

• Detects RSV antigen
• Uses nasal or nasopharyngeal swab specimens
• Rapid visual result
• Simple test procedure
• No complex instrument required
• Useful for respiratory infection screening
• Supports pediatric and respiratory care workflows
• Suitable for professional point-of-care testing

The RSV Ag Rapid Test Device is designed for nasal swab and nasopharyngeal swab specimens. Proper specimen collection and handling are important for reliable rapid test performance.

Guidance

• Use approved nasal or nasopharyngeal swab specimens only
• Collect specimens according to the product insert
• Use clean and suitable swab collection materials
• Avoid contaminated or improperly collected samples
• Mix the swab specimen with extraction buffer correctly
• Apply the processed sample properly to the test device
• Read results only within the recommended time window
• Handle respiratory specimens according to laboratory safety procedures

Note

Specimen collection, extraction, testing, timing, and storage should always follow the official LARKSOIS Pharma kit insert.

The RSV Ag Rapid Test Device by LARKSOIS Pharma is designed for qualitative detection of Respiratory Syncytial Virus antigen in nasal or nasopharyngeal swab specimens. Detection of RSV antigen may support rapid screening of suspected respiratory syncytial virus infection.

• A positive result means RSV antigen has been detected in the specimen.
• The result should be interpreted with symptoms, respiratory illness activity, and patient history.
• A negative result does not completely rule out RSV infection if symptoms continue or specimen collection timing is not optimal.
• Additional laboratory testing such as PCR may be recommended if clinical suspicion remains high.

The RSV Ag Rapid Test Device is a professional screening aid and should not be used as the only basis for diagnosis. Test performance may depend on specimen quality, timing of collection, viral load, and correct procedure.

Instructions

• For professional in-vitro diagnostic use only
• Use approved respiratory specimens only
• Improper specimen collection may affect results
• False positive or false negative results may occur
• Negative results may require further testing if symptoms continue
• Clinical evaluation should guide final diagnosis and patient management
• Read results only within the recommended time
• Follow the official product insert carefully

Instructions

• Detects RSV antigen
• Uses nasal or nasopharyngeal swab specimens
• Rapid visual result
• Simple test procedure
• No complex instrument required
• Useful for respiratory infection screening
• Supports pediatric and respiratory care workflows
• Suitable for international healthcare supply

Note

The RSV Ag Rapid Test Device by LARKSOIS Pharma is designed for fast, practical, and accessible respiratory infection screening support.

Steps

• Bring the test device, specimen, and extraction buffer to room temperature
• Collect the nasal or nasopharyngeal swab specimen according to the instructions
• Place the swab into the extraction buffer tube
• Mix the sample properly as instructed in the product insert
• Remove the test cassette from the sealed pouch
• Apply the processed sample to the sample well
• Wait for the recommended reaction time
• Read the test and control lines within the valid time window
• Dispose of used materials according to laboratory safety procedures

Note

Testing should be performed by trained healthcare professionals according to the official LARKSOIS Pharma product insert.

Positive

A positive result means RSV antigen has been detected in the respiratory specimen. The result should be interpreted with symptoms and clinical evaluation.

Negative

A negative result means RSV antigen was not detected at the test’s detectable level. If symptoms continue or clinical suspicion remains high, further testing may be required.

Invalid

If the control line does not appear, the result is invalid. Repeat the test with a new device.

Instructions

• Store the RSV Ag Rapid Test Device according to the product label and insert
• Store in a cool and dry place
• Keep sealed until use
• Protect from heat, sunlight, and moisture
• Do not freeze unless specified
• Do not use expired kits
• Use immediately after opening the pouch
• Follow all instructions for use carefully

Instructions

• For professional in-vitro diagnostic use only
• Handle respiratory specimens carefully
• Wear gloves and protective equipment during testing
• Do not reuse the test cassette
• Avoid specimen contamination
• Do not use damaged or expired kits
• Read results only within the recommended time
• Interpret results with symptoms and clinical findings

LARKSOIS Pharma provides internationally suitable diagnostic products for hospitals, laboratories, clinics, healthcare distributors, and public health programs. The RSV Ag Rapid Test Device offers a practical solution for rapid respiratory syncytial virus screening.

Advantages

• International infectious disease rapid test portfolio
• Reliable RSV antigen screening support
• Suitable for hospitals, clinics, and laboratories
• Distributor-friendly product support
• Professional healthcare quality standards
• Practical point-of-care diagnostic format
• Accessible respiratory infection screening solution